Aion Therapeutic Inc.
ANTCF
$0.0037
-$0.0073-66.36%
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -233.81% | -69.49% | -115.03% | 149.15% | -148.81% |
| Total Depreciation and Amortization | -97.67% | -2.27% | 2.33% | 230.77% | -90.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 778.29% | -341.38% | 103.27% | -209.30% | 4,266.13% |
| Change in Net Operating Assets | 25.15% | 104.18% | -65.12% | -59.44% | 17.26% |
| Cash from Operations | 225.87% | -1,581.67% | 109.51% | -785.87% | 111.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | -- | -- | 515.20% |
| Total Debt Issued | -94.57% | -76.77% | -43.02% | 94.41% | -36.50% |
| Total Debt Repaid | 99.93% | -2,114.06% | 75.57% | -- | 100.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.66% | -170.44% | 48.12% | 55.50% | -26.18% |
| Foreign Exchange rate Adjustments | -260.43% | 150.54% | -1,104.35% | 82.86% | -1,037.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.00% | -284.62% | -119.70% | 980.00% | 78.26% |
